{
  "symbol": "FHTX",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "small-cap company", "clinical-stage developments"],
    "riskScore": 7,
    "reason": "Foghorn Therapeutics operates in the biotech sector, is a small-cap company, and focuses on clinical-stage developments, making it susceptible to retail-driven speculation."
  }
}